Literature DB >> 14988826

Cholic acid supplementation enhances cholesterol absorption in humans.

Laura A Woollett1, Donna D Buckley, Lihang Yao, Peter J H Jones, Norman A Granholm, Elizabeth A Tolley, Patrick Tso, James E Heubi.   

Abstract

BACKGROUND & AIMS: Qualitative and quantitative changes in intralumenal bile acid composition may alter cholesterol absorption and synthesis and low-density lipoprotein (LDL) receptor expression. The role of cholic acid (CA) in cholesterol absorption in humans remains unclear and, thus, was examined in the current study.
METHODS: In a crossover design outpatient study, 12 adults aged 24-36 years took 15 mg/kg/day (CA) or no bile acid supplement (control) while being fed a controlled diet (AHA heart-healthy diet). A liquid meal of defined composition was given on day 14 of the diet, and lumenal samples were collected. Thereafter, cholesterol absorption and cholesterol fractional synthetic rate (FSR) were assessed by stable isotopic methods from days 16 to 20.
RESULTS: With CA treatment, bile was enriched significantly with CA (P < 0.0004) to 60.2% +/- 2.4% (mean +/- SEM) compared with 43.3% +/- 2.4% for controls. CA plus diet treatment significantly increased (P = 0.013) cholesterol absorption (72.6% +/- 2.9%) compared with diet treatment alone (60.4% +/- 2.9%). Percentage micellar cholesterol was increased by CA plus diet treatment vs. diet alone after meal ingestion (P = 0.004). Plasma total and high-density lipoprotein (HDL) and LDL cholesterol was unchanged with CA treatment.
CONCLUSIONS: Thus, enrichment in lumenal bile with CA results in an increase in cholesterol absorption, an effect potentially mediated by enhanced cholesterol solubilization in micelles.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14988826     DOI: 10.1053/j.gastro.2003.11.058

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  19 in total

1.  Abolished synthesis of cholic acid reduces atherosclerotic development in apolipoprotein E knockout mice.

Authors:  Katharina Slätis; Mats Gåfvels; Kristina Kannisto; Olga Ovchinnikova; Gabrielle Paulsson-Berne; Paolo Parini; Zhao-Yan Jiang; Gösta Eggertsen
Journal:  J Lipid Res       Date:  2010-07-30       Impact factor: 5.922

2.  Activation of PPARα decreases bile acids in livers of female mice while maintaining bile flow and biliary bile acid excretion.

Authors:  Youcai Zhang; Andrew J Lickteig; Iván L Csanaky; Curtis D Klaassen
Journal:  Toxicol Appl Pharmacol       Date:  2017-11-22       Impact factor: 4.219

3.  Individual bile acids have differential effects on bile acid signaling in mice.

Authors:  Peizhen Song; Cheryl E Rockwell; Julia Yue Cui; Curtis D Klaassen
Journal:  Toxicol Appl Pharmacol       Date:  2015-01-09       Impact factor: 4.219

Review 4.  Revisiting Human Cholesterol Synthesis and Absorption: The Reciprocity Paradigm and its Key Regulators.

Authors:  Peter A S Alphonse; Peter J H Jones
Journal:  Lipids       Date:  2015-11-30       Impact factor: 1.880

5.  Augmented cholesterol absorption and sarcolemmal sterol enrichment slow small intestinal transit in mice, contributing to cholesterol cholelithogenesis.

Authors:  Meimin Xie; Vijay R Kotecha; Jon David P Andrade; James G Fox; Martin C Carey
Journal:  J Physiol       Date:  2012-02-13       Impact factor: 5.182

6.  Cholesterol feeding prevents hepatic accumulation of bile acids in cholic acid-fed farnesoid X receptor (FXR)-null mice: FXR-independent suppression of intestinal bile acid absorption.

Authors:  Masaaki Miyata; Yoshiki Matsuda; Masahiro Nomoto; Yuki Takamatsu; Nozomi Sato; Mayumi Hamatsu; Paul A Dawson; Frank J Gonzalez; Yasushi Yamazoe
Journal:  Drug Metab Dispos       Date:  2008-11-06       Impact factor: 3.922

7.  Cholic acid for hepatic steatosis in patients with lipodystrophy: a randomized, controlled trial.

Authors:  Zahid Ahmad; Lalitha Subramanyam; Lidia Szczepaniak; Vinaya Simha; Beverley Adams-Huet; Abhimanyu Garg
Journal:  Eur J Endocrinol       Date:  2013-04-15       Impact factor: 6.664

8.  Decreased plasma cholesterol concentrations after PUFA-rich diets are not due to reduced cholesterol absorption/synthesis.

Authors:  Vanu R Ramprasath; Peter J H Jones; Donna D Buckley; Laura A Woollett; James E Heubi
Journal:  Lipids       Date:  2012-09-11       Impact factor: 1.880

9.  NPC1L1 and SR-BI are involved in intestinal cholesterol absorption from small-size lipid donors.

Authors:  Ziad Haikal; Barbara Play; Jean-François Landrier; Annie Giraud; Odette Ghiringhelli; Denis Lairon; Dominique Jourdheuil-Rahmani
Journal:  Lipids       Date:  2008-03-29       Impact factor: 1.880

10.  Chronic Activation of Liver X Receptor Sensitizes Mice to High Cholesterol Diet-Induced Gut Toxicity.

Authors:  Wojciech G Garbacz; Hirdesh Uppal; Jiong Yan; Meishu Xu; Songrong Ren; Donna B Stolz; Min Huang; Wen Xie
Journal:  Mol Pharmacol       Date:  2018-07-25       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.